Associate Professor of Thoracic Surgery, University Utah
Thoracic Surgery
Dr. David A. Bull, MD
|
|
Give Review
David A. Bull works in the field of Thoracic Surgery. He studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a one of the best medicals schools. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care He over the years received 5 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Good Housekeeping: Top Heart Centers for Women" and "Fellow (FACS)". Doctor David A. Bull, MD is a published doctor. He has 95 papers published. The most current publication "Postoperative ulnar neuropathy associated with prolonged ischemia in the upper extremity during coronary artery bypass surgery."
Publications
- Carotid Artery Stenosis in the Setting of Transcatheter Aortic Valve Replacement: Clinical and Technical Considerations of Carotid Stenting.
- Myocardial Stiffness in Patients with Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin.
- Functional polymers of gene delivery for treatment of Myocardial infarct.
- Safety and Efficacy of Ixmyelocel-T: An Expanded, Autologous Multi-Cellular Therapy, in Dilated Cardiomyopathy.
- Cell surface engineering to enhance mesenchymal stem cell migration toward an SDF-1 gradient.
- Metabolically active human brown adipose tissue derived stem cells.
- Endovascular Repair of Acute Ascending Aortic Disruption via the Right Axillary Artery.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Synergistically Combined Gene Delivery for Enhanced VEGF Secretion and Antiapoptosis.
- Historical perspectives of The American Association for Thoracic Surgery: Frank Gerbode (1907-1984).
- Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of Myocardial ischemia.
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in Heart failure with preserved ejection fraction: a randomized clinical trial.
- Impella 5.0 support in severe peripheral vascular Disease via iliac artery approach.
- Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier.
- Hypoxia-inducible plasmid expressing both miSHP-1 and HO-1 for the treatment of ischemic Disease.
- Obesity and the Response to Intensified Diuretic Treatment in Decompensated Heart Failure: A DOSE Trial Substudy.
- Mesenchymal stem cell population isolated from the sub-epithelial layer of umbilical cord tissue.
- Magnetic resonance imaging (MRI) assessment of ventricular remodeling after Myocardial infarction in rabbits.
- Dendrimer type bio-reducible polymer for efficient gene delivery.
- Cell Targeting Peptide Conjugation to siRNA Polyplexes for Effective Gene Silencing in Cardiomyocytes.
- Putative population of adipose derived stem cells isolated from Mediastinal tissue during cardiac surgery.
- Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion.
- Improved survival in Heart transplant patients living at high altitude.
- Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.
- Allograft rejection in patients supported with continuous-flow left ventricular assist devices.
- Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery.
- Ligation of the left circumflex Coronary artery with subsequent MRI and histopathology in rabbits.
- The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
- Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and Heart transplantation.
- Utility of virtual crossmatch in sensitized patients awaiting Heart transplantation.
- VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine).
- Effect of work-hour restriction on operative experience in cardiothoracic surgical residency training.
- Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity.
- Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients.
- Early screening for antibody-mediated rejection in Heart transplant recipients.
- Postoperative Pericardial adhesion prevention using Carbylan-SX in a rabbit model.
- Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary Artery smooth muscle cells.
- Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic Disease.
- Aprotinin and preservation of Myocardial function after ischemia-reperfusion injury.
- Outcomes after esophagectomy: a ten-year prospective cohort.
- PDGF(BB) increases Myocardial production of VEGF: shift in VEGF mRNA splice variants after direct injection of bFGF, PDGF(BB), and PDGF(AB).
- Thrombosis of a descending thoracic Aortic endovascular stent graft in a patient with factor V Leiden: case report.
- Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 w...
- Antibodies against human herpesvirus 8 in black South African patients with Cancer.
- Correlation of ophthalmic findings with Carotid artery stenosis.
- Thrombectomy and isolated limb perfusion with urokinase in the treatment of phlegmasia cerulea dolens.
- Immunophenotyping in the management of gastric lymphoma.
- Cloning and characterisation of the human 5-HT5A serotonin receptor.
- Hypoxemia from an Atrial septal defect 7 days after blunt thoracic trauma.
- The Acutely affected abdomen in paraplegic spinal cord injury patients.
- Atherosclerotic Aneurysms of the axillary artery. A report of two cases and a review of the literature.
- Putative Vascular endothelial cell chemotactic factors: comparison in a standardized migration assay.
- Postoperative ulnar neuropathy associated with prolonged ischemia in the upper extremity during Coronary artery bypass surgery.
- Prospective evaluation of peripheral vascular Disease in heart transplant recipients.
- Intraoperative diagnosis and treatment of Pleural effusion based on transesophageal echocardiographic findings.
- Contrast-induced nephrotoxicity: the effects of vasodilator therapy.
- Peripheral vascular Disease in heart transplant recipients.
- Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following Myocardial infarct.
- Improved sterile technique diminishes the incidence of positive line cultures in cardioVascular patients.
- Subjective assessment of left ventricular preload using transesophageal echocardiography: corresponding pulmonary Artery occlusion pressures.
- Ruptured sinus of Valsalva Aneurysm in a patient with autosomal dominant polycystic kidney disease.
- Predictors of outcome of mammography in the National Health Service Breast Screening Programme.
- Improved biochemical preservation of Heart slices during cold storage.
- Cellular origin and rate of endothelial cell coverage of PTFE grafts.
- Functional outcome and survival after pharyngolaryngoesophagectomy for Cancer.
- Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection.
- Risk factors for stroke in patients undergoing Coronary artery bypass grafting.
- Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium.
- Interleukin-18 production following murine cardiac transplantation: correlation with histologic rejection and the induction of INF-gamma.
- Improved biochemical preservation of Lung slices during cold storage.
- The high risk Heart donor: potential pitfalls.
- The effects of improved hemodynamics on Aortic dimensions in patients undergoing heart transplantation.
- Effect of a resident self-study and presentation program on performance on the thoracic surgery in-training examination.
- Aprotinin preserves Myocardial biochemical function during cold storage through suppression of tumor necrosis factor.
- Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization.
- Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
- Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients.
- Augmentation of Myocardial transfection using TerplexDNA: a novel gene delivery system.
- Coronary artery bypass grafting with cardiopulmonary bypass versus off-pump cardiopulmonary bypass grafting: does eliminating the pump reduce morbidity and cost?
- Patch closure of the Aortic anulus in a recipient of a ventricular assist device.
- Long-term results of cardiac transplantation in patients older than sixty years. UTAH Cardiac Transplant Program.
- Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery.
- Multivariate predictors of heart transplantation outcomes in the era of Chronic mechanical circulatory support.
- Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3''-untranslated region for the VEGF gene therapy.
- Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis.
- Novel polymer carriers and gene constructs for treatment of Myocardial ischemia and infarction.
- A family of bioreducible poly(disulfide amine)s for gene delivery.
- Women and heart Disease--physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ische...
- Reductive degradation behavior of bioreducible poly(disulfide amine) for enhancing SiRNA efficiency.
- Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation.
- Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to Acutely ischemic myocardium.
- Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following Myocardial infarction. VEGF gene therapy for Myocardial infarction.
- Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium.
- Diuretic strategies in patients with Acute decompensated heart failure.
Schools
University of California At San Francisco
Ucsf Hospital
University Ariz Hosps
University of Utah
Procedures Preformed
- Aortic Repair, Open or Repair of Arterial Aneurysm, Open
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- Chest CT (incl. Heart and Lungs)
- View All
Conditions Treated
- Abdominal Aortic Aneurysm (AAA)
- Acute Venous Embolism Thrombosis
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- View All
Doctors Specialties
- Cardiac Surgery
- Critical Care Surgery
- Thoracic Surgery
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Good Housekeeping: Top Heart Centers for Women
- Fellow (FACS)
Education
-
University of Utah -
University of Arizona -
UCSF -
University of California San Francisco School of Medicine
Hospital
-
University of Utah Health Care - Hospital and Clinics
Drug Facts
| NPI NUMBER | 1497845085 | |
| NPPES Provider LastName | BULL | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 841320001 | |
| NPPES Provider State | UT | |
| Specialty Description | General Practice | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497845085 |
| Last Name Of The Provider | BULL |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. John R. Doty, MD |
|
|
Dr. James C. Stringham, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Gilbert R. Schorlemmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen H. McKellar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David G. Affleck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip T. Burch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raminder Nirula, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven R. Granger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard G. Barton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron W. Eckhauser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clynn R. Ford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen E. Clayson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin C. McGough, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John B. Sorensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy J. Gayowski, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jesse L. Madden, MD
This Doctor is OpenDoctor Recommended.
|